The Biostatistics Core (Core C) will bridge the transition from the DIAN database stored and managed bythe Informatics Core (Core H) to the analyses of the longitudinal data within, between, and among thevarious data domains, the latter of which serves as the primary responsibility of the Core. Specifically theBiostatistics Core will: (1) oversee the statistical quality control of data for the study and produceappropriately de-identified and statistically analyzable datasets for distribution/analysis; (2) lead the statisticaldata analyses and collaborate in report preparation for all Cores and projects, and consult on the design ofall projects and on the application of appropriate statistical and methodological techniques; (3) develop andimplement appropriate statistical models for longitudinal changes in potential markers and use these modelsto test the statistical hypotheses about the preclinical changes of AD and about the temporal difference onpreclinical changes of AD among various markers, and (4) serve as an advisory group for other researchersinterested in using the DIAN database for additional analyses. The Biostatistics core will achieve thesespecific aims through extensive interactions and collaborations with all other components of DIAN.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project--Cooperative Agreements (U01)
Project #
1U01AG032438-01
Application #
7670949
Study Section
Special Emphasis Panel (ZAG1-ZIJ-1 (M1))
Project Start
2008-09-15
Project End
2014-06-30
Budget Start
2008-09-15
Budget End
2009-06-30
Support Year
1
Fiscal Year
2008
Total Cost
$53,238
Indirect Cost
Name
Washington University
Department
Type
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Roe, Catherine M; Babulal, Ganesh M; Stout, Sarah H et al. (2018) Using the A/T/N Framework to Examine Driving in Preclinical AD. Geriatrics (Basel) 3:
Suárez-Calvet, Marc; Capell, Anja; Araque Caballero, Miguel Ángel et al. (2018) CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline. EMBO Mol Med 10:
Besser, Lilah; Kukull, Walter; Knopman, David S et al. (2018) Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set. Alzheimer Dis Assoc Disord 32:351-358
Kinnunen, Kirsi M; Cash, David M; Poole, Teresa et al. (2018) Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial magnetic resonance imaging study. Alzheimers Dement 14:43-53
Lee, Seonjoo; Zimmerman, Molly E; Narkhede, Atul et al. (2018) White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer's disease. PLoS One 13:e0195838
Xiong, Chengjie; Luo, Jingqin; Chen, Ling et al. (2018) Estimating diagnostic accuracy for clustered ordinal diagnostic groups in the three-class case-Application to the early diagnosis of Alzheimer disease. Stat Methods Med Res 27:701-714
Jacobs, Heidi I L; Hedden, Trey; Schultz, Aaron P et al. (2018) Structural tract alterations predict downstream tau accumulation in amyloid-positive older individuals. Nat Neurosci 21:424-431
Gabel, Matthew; Gooblar, Jonathan; Roe, Catherine M et al. (2018) Political Ideology, Confidence in Science, and Participation in Alzheimer Disease Research Studies. Alzheimer Dis Assoc Disord 32:179-184
Twohig, Daniel; Rodriguez-Vieitez, Elena; Sando, Sigrid B et al. (2018) The relevance of cerebrospinal fluid ?-synuclein levels to sporadic and familial Alzheimer's disease. Acta Neuropathol Commun 6:130
Joseph-Mathurin, Nelly; Su, Yi; Blazey, Tyler M et al. (2018) Utility of perfusion PET measures to assess neuronal injury in Alzheimer's disease. Alzheimers Dement (Amst) 10:669-677

Showing the most recent 10 out of 108 publications